The Use of Eltrombopag Post HSCT in BMFD
NCT05466201
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
118
Enrollment
OTHER
Sponsor class
Conditions
Stem Cell Transplant Complications
Interventions
DRUG:
Eltrombopag 25 MG Oral Tablet
DRUG:
Supportive care
Sponsor
The First Affiliated Hospital of Soochow University